Showing results (1831-1840 of 1,996) with videos related to

Sort By:
Pageof 200
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and TrapperGiuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
Hospital Pediatrics|June 16, 2025
Specialty Consultations and Diagnostic Testing Accuracy After Brief Resolved Unexplained Events: A Multicenter Observational StudyNassr Nama, Praveen Jayson Rajasegaran, Lauren M McDaniel, et al.
European Urology Focus|March 15, 2022
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell CarcinomasAngela Yoo, Cerise Tang, Mark Zucker, et al.
The Oncologist|June 20, 2020
ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance ProfilingMalinda Itchins, Brandon Lau, Amanda L Hudson, et al.
Journal of Hospital Medicine|June 26, 2024
Parenteral versus enteral fluids for infants hospitalized with bronchiolitis: The PREFER shared decision-making prospective observational study protocolPeter J Gill, Francine Buchanan, Christine Fahim, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian PopulationTamkin Ahmadzada, Wendy A Cooper, Mikaela Holmes, et al.
Pageof 200